Aron-Wisnewsky J - Search Results

1

Bariatric Surgery Induces Disruption in Inflammatory Signaling Pathways Mediated by Immune Cells in Adipose Tissue: A RNA-Seq Study.

Poitou C, Perret C, Mathieu F, Truong V, Blum Y, Durand H, Alili R, Chelghoum N, Pelloux V, Aron-Wisnewsky J, Torcivia A, Bouillot JL, Parks BW, Ninio E, Clément K, Tiret L. Poitou C, et al. PLoS One. 2015 May 4;10(5):e0125718. doi: 10.1371/journal.pone.0125718. eCollection 2015. PLoS One. 2015. PMID: 25938420 Free PMC article.

2

Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss.

Aron-Wisnewsky J, Tordjman J, Poitou C, Darakhshan F, Hugol D, Basdevant A, Aissat A, Guerre-Millo M, Clément K. Aron-Wisnewsky J, et al. J Clin Endocrinol Metab. 2009 Nov;94(11):4619-23. doi: 10.1210/jc.2009-0925. Epub 2009 Oct 16. J Clin Endocrinol Metab. 2009. PMID: 19837929

3

Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women.

Aron-Wisnewsky J, Julia Z, Poitou C, Bouillot JL, Basdevant A, Chapman MJ, Clement K, Guerin M. Aron-Wisnewsky J, et al. J Clin Endocrinol Metab. 2011 Apr;96(4):1151-9. doi: 10.1210/jc.2010-2378. Epub 2011 Feb 2. J Clin Endocrinol Metab. 2011. PMID: 21289254

4

Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.

Aron-Wisnewsky J, Minville C, Tordjman J, Lévy P, Bouillot JL, Basdevant A, Bedossa P, Clément K, Pépin JL. Aron-Wisnewsky J, et al. J Hepatol. 2012 Jan;56(1):225-33. doi: 10.1016/j.jhep.2011.04.022. Epub 2011 May 19. J Hepatol. 2012. PMID: 21703181

5

The importance of the gut microbiota after bariatric surgery.

Aron-Wisnewsky J, Doré J, Clement K. Aron-Wisnewsky J, et al. Nat Rev Gastroenterol Hepatol. 2012 Oct;9(10):590-8. doi: 10.1038/nrgastro.2012.161. Epub 2012 Aug 28. Nat Rev Gastroenterol Hepatol. 2012. PMID: 22926153 Review.

6

Gut microbiota and non-alcoholic fatty liver disease: new insights.

Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K. Aron-Wisnewsky J, et al. Clin Microbiol Infect. 2013 Apr;19(4):338-48. doi: 10.1111/1469-0691.12140. Epub 2013 Mar 2. Clin Microbiol Infect. 2013. PMID: 23452163 Free article. Review.

7

Pharmacokinetics of immunomodulator treatments after roux-en-y bypass in obese patient.

Aron-Wisnewsky J, Lemaitre F, Clément K, Bouillot JL, Fernandez C, Basdevant A, Oppert JM, Buyse M. Aron-Wisnewsky J, et al. J Clin Pharmacol. 2013 Jul;53(7):779-84. doi: 10.1002/jcph.99. Epub 2013 May 14. J Clin Pharmacol. 2013. PMID: 23670812 No abstract available.

8

Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes.

Kong LC, Tap J, Aron-Wisnewsky J, Pelloux V, Basdevant A, Bouillot JL, Zucker JD, Doré J, Clément K. Kong LC, et al. Am J Clin Nutr. 2013 Jul;98(1):16-24. doi: 10.3945/ajcn.113.058743. Epub 2013 May 29. Am J Clin Nutr. 2013. PMID: 23719559 Free article.

9

Noninvasive diagnosis of nonalcoholic steatohepatitis disease based on clinical decision support system.

Douali N, Abdennour M, Sasso M, Miette V, Tordjman J, Bedossa P, Veyrie N, Poitou C, Aron-Wisnewsky J, Clément K, Jaulent MC, Zucker JD. Douali N, et al. Stud Health Technol Inform. 2013;192:1178. Stud Health Technol Inform. 2013. PMID: 23920952

10

Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea.

Minville C, Hilleret MN, Tamisier R, Aron-Wisnewsky J, Clement K, Trocme C, Borel JC, Lévy P, Zarski JP, Pépin JL. Minville C, et al. Chest. 2014 Mar 1;145(3):525-533. doi: 10.1378/chest.13-0938. Chest. 2014. PMID: 24264333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page